Masafumi Kitakaze

39.5k citations
474 papers · 19.4k indexed · 1 hit paper · h-index 74
Topics
Cardiac Ischemia and Reperfusion (95 papers)Cardiovascular Function and Risk Factors (79 papers)Heart Failure Treatment and Management (60 papers)
Partner nations
JapanUnited StatesChina

In The Last Decade

Masafumi Kitakaze

465 papers receiving 19.0k citations

Hit Papers

Cardiac hypertrophy is inhibited by antagonism of ADAM12 ...20022026201020182002100200300400500

Peers

Masafumi Kitakaze
Comparison fields: 5 of 157
  • Cardiology and Cardiovascular Medicine 8.2k
  • Molecular Biology 6.1k
  • Pathology and Forensic Medicine 3.8k
  • Surgery 3.1k
  • Physiology 2.8k
Replace Masatsugu Hori with:
Masatsugu Hori Japan
Tetsuji Miura Japan
Charles Steenbergen United States
Naranjan S. Dhalla Canada
Roberto Bolli United States
Kazuaki Shimamoto Japan
Rakesh C. Kukreja United States
Walter J. Koch United States
Gary D. Lopaschuk Canada
Hisayoshi Fujiwara Japan
Masafumi Kitakaze relative to Masatsugu Hori Japan Masatsugu Hori's profile →
Citations per field
00.5×1.5×
Masatsugu Hori · 1×
Citations per year

Countries citing papers authored by Masafumi Kitakaze

Since Specialization
Citations

This map shows the geographic impact of Masafumi Kitakaze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masafumi Kitakaze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masafumi Kitakaze more than expected).

Fields of papers citing papers by Masafumi Kitakaze

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masafumi Kitakaze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masafumi Kitakaze. The network helps show where Masafumi Kitakaze may publish in the future.

Co-authorship network of co-authors of Masafumi Kitakaze

This figure shows the co-authorship network connecting the top 25 collaborators of Masafumi Kitakaze. A scholar is included among the top collaborators of Masafumi Kitakaze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masafumi Kitakaze. Masafumi Kitakaze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 6
3 1
4 1
5 64
6
LATE BREAKING CLINICAL TRIAL (JCS 2017) : AVJ-514 Trial : Baseline Characteristics and 30-Day Outcomes Following MitraClip Treatment in a Japanese Cohort
2
7 50
8 0
9
Patients with FPE Showed Fluid Redistribution, and Rapidly Improved of Condition by Initial Treatment with NIV
0
10
PACIFICレジストリ(虚血性冠動脈疾患後のアテローム血栓疾患予防):日本の冠不全症候群の初期入院患者2年間試験の基本データ
14
11
Acute myocardial infarction due to thrombosis in the right sinus of Valsalva in a young woman
0
12 1
13 84
14
Abstract 2948: Sustained After-Effects of Carperitide, Atrial Natriuretic Peptide, on Left Ventricle Diastolic Filling and Inflammatory Cytokines in Idiopathic Dilated Cardiomyopathy
1
15
2 How to Find Novel Pathophysiology and Therapy of Chronic Heart Failure from Genomic Database(Perspectives of Genome-wide Study to Identify Genes Underlying Cardiovascular Diseases,Roundtable Discussion 10 (RT10) (M),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
1
16 292
17
Asymmetrical Dimethyl Arginine (ADMA) is a Novel Marker of Coronary Stent Restenosis
3
18
Changes in myocardial gene expression associated with betablocker therapy in patients with chronic heart failure
6
19 55
20
IS174 Inhibition of Cardiomyocyte Hypertrophy by Estrogen
2

About Masafumi Kitakaze

Masafumi Kitakaze is a scholar working on Cardiology and Cardiovascular Medicine, Developmental Neuroscience and Pathology and Forensic Medicine, having authored 474 papers that have together received 19.4k indexed citations. Recurring topics across this work include Cardiac Ischemia and Reperfusion (95 papers), Cardiovascular Function and Risk Factors (79 papers) and Heart Failure Treatment and Management (60 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (8.2k citations), Developmental Neuroscience (1.1k citations) and Pathology and Forensic Medicine (3.8k citations). Masafumi Kitakaze has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Tetsuo Minamino, Masatsugu Hori, Koichi Node, Seiji Takashima, Masanori Asakura, Hiroshi Asanuma, Shoji Sanada, Yulin Liao, Kazuo Komamura and Issei Komuro. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026